FDA Drug Recalls

Recalls / Class II

Class IID-0359-2023

Product

Phenylephrine HCl Injection, USP, 1 mg/10 mL (100 mcg/mL), 10 mL Single-Dose Vial, packaged in 30 x 10 mL Sterile Single-Dose Vials per carton, 12 x 30 Vials Carton per case, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC 69374-302-10.

Affected lot / code info
Lots: PE2025, Exp. 05/28/2023; PE2026, Exp. 06/02/2023; PE2027, Exp. 06/04/2023; PE2030, Exp. 06/29/2023; PE2031, Exp. 06/27/2023; PE2032, Exp. 07/09/2023; PE2032A, Exp. 07/09/2023; PE2033, Exp. 08/03/2023; PE2034, Exp. 08/31/2023; PE2035, Exp. 09/11/2023

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Nephron Sterile Compounding Center LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
4500 12th Street Ext, N/A, West Columbia, South Carolina 29172-3025

Distribution

Quantity
546,450 vials
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2023-02-22
FDA classified
2023-02-27
Posted by FDA
2023-03-08
Terminated
2024-09-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0359-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls